Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Prescription Dermatological Medications Market Growth 2022-2028

  • LP 4798996
  • 96 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Prescription Dermatological Medications will have significant change from previous year. According to our (LP Information) latest study, the global Prescription Dermatological Medications market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Prescription Dermatological Medications market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Prescription Dermatological Medications market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Prescription Dermatological Medications market, reaching US$ million by the year 2028. As for the Europe Prescription Dermatological Medications landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Prescription Dermatological Medications players cover Mylan Pharmaceuticals, Pfizer, Almirall, and Bausch Health, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Prescription Dermatological Medications market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Oral

Topical

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Mylan Pharmaceuticals

Pfizer

Almirall

Bausch Health

Barrier Therapeutics

PharmaDerm

Bristol-Myers Squibb

Galderma

Novartis

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Prescription Dermatological Medications Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Prescription Dermatological Medications by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Prescription Dermatological Medications by Country/Region, 2017, 2022 & 2028

2.2 Prescription Dermatological Medications Segment by Type

2.2.1 Oral

2.2.2 Topical

2.3 Prescription Dermatological Medications Sales by Type

2.3.1 Global Prescription Dermatological Medications Sales Market Share by Type (2017-2022)

2.3.2 Global Prescription Dermatological Medications Revenue and Market Share by Type (2017-2022)

2.3.3 Global Prescription Dermatological Medications Sale Price by Type (2017-2022)

2.4 Prescription Dermatological Medications Segment by Application

2.4.1 Hospital Pharmacies

2.4.2 Online Pharmacies

2.4.3 Retail Pharmacies

2.5 Prescription Dermatological Medications Sales by Application

2.5.1 Global Prescription Dermatological Medications Sale Market Share by Application (2017-2022)

2.5.2 Global Prescription Dermatological Medications Revenue and Market Share by Application (2017-2022)

2.5.3 Global Prescription Dermatological Medications Sale Price by Application (2017-2022)

3 Global Prescription Dermatological Medications by Company

3.1 Global Prescription Dermatological Medications Breakdown Data by Company

3.1.1 Global Prescription Dermatological Medications Annual Sales by Company (2020-2022)

3.1.2 Global Prescription Dermatological Medications Sales Market Share by Company (2020-2022)

3.2 Global Prescription Dermatological Medications Annual Revenue by Company (2020-2022)

3.2.1 Global Prescription Dermatological Medications Revenue by Company (2020-2022)

3.2.2 Global Prescription Dermatological Medications Revenue Market Share by Company (2020-2022)

3.3 Global Prescription Dermatological Medications Sale Price by Company

3.4 Key Manufacturers Prescription Dermatological Medications Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Prescription Dermatological Medications Product Location Distribution

3.4.2 Players Prescription Dermatological Medications Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Prescription Dermatological Medications by Geographic Region

4.1 World Historic Prescription Dermatological Medications Market Size by Geographic Region (2017-2022)

4.1.1 Global Prescription Dermatological Medications Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Prescription Dermatological Medications Annual Revenue by Geographic Region

4.2 World Historic Prescription Dermatological Medications Market Size by Country/Region (2017-2022)

4.2.1 Global Prescription Dermatological Medications Annual Sales by Country/Region (2017-2022)

4.2.2 Global Prescription Dermatological Medications Annual Revenue by Country/Region

4.3 Americas Prescription Dermatological Medications Sales Growth

4.4 APAC Prescription Dermatological Medications Sales Growth

4.5 Europe Prescription Dermatological Medications Sales Growth

4.6 Middle East & Africa Prescription Dermatological Medications Sales Growth

5 Americas

5.1 Americas Prescription Dermatological Medications Sales by Country

5.1.1 Americas Prescription Dermatological Medications Sales by Country (2017-2022)

5.1.2 Americas Prescription Dermatological Medications Revenue by Country (2017-2022)

5.2 Americas Prescription Dermatological Medications Sales by Type

5.3 Americas Prescription Dermatological Medications Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Prescription Dermatological Medications Sales by Region

6.1.1 APAC Prescription Dermatological Medications Sales by Region (2017-2022)

6.1.2 APAC Prescription Dermatological Medications Revenue by Region (2017-2022)

6.2 APAC Prescription Dermatological Medications Sales by Type

6.3 APAC Prescription Dermatological Medications Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Prescription Dermatological Medications by Country

7.1.1 Europe Prescription Dermatological Medications Sales by Country (2017-2022)

7.1.2 Europe Prescription Dermatological Medications Revenue by Country (2017-2022)

7.2 Europe Prescription Dermatological Medications Sales by Type

7.3 Europe Prescription Dermatological Medications Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Prescription Dermatological Medications by Country

8.1.1 Middle East & Africa Prescription Dermatological Medications Sales by Country (2017-2022)

8.1.2 Middle East & Africa Prescription Dermatological Medications Revenue by Country (2017-2022)

8.2 Middle East & Africa Prescription Dermatological Medications Sales by Type

8.3 Middle East & Africa Prescription Dermatological Medications Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Prescription Dermatological Medications

10.3 Manufacturing Process Analysis of Prescription Dermatological Medications

10.4 Industry Chain Structure of Prescription Dermatological Medications

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Prescription Dermatological Medications Distributors

11.3 Prescription Dermatological Medications Customer

12 World Forecast Review for Prescription Dermatological Medications by Geographic Region

12.1 Global Prescription Dermatological Medications Market Size Forecast by Region

12.1.1 Global Prescription Dermatological Medications Forecast by Region (2023-2028)

12.1.2 Global Prescription Dermatological Medications Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Prescription Dermatological Medications Forecast by Type

12.7 Global Prescription Dermatological Medications Forecast by Application

13 Key Players Analysis

13.1 Mylan Pharmaceuticals

13.1.1 Mylan Pharmaceuticals Company Information

13.1.2 Mylan Pharmaceuticals Prescription Dermatological Medications Product Offered

13.1.3 Mylan Pharmaceuticals Prescription Dermatological Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Mylan Pharmaceuticals Main Business Overview

13.1.5 Mylan Pharmaceuticals Latest Developments

13.2 Pfizer

13.2.1 Pfizer Company Information

13.2.2 Pfizer Prescription Dermatological Medications Product Offered

13.2.3 Pfizer Prescription Dermatological Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Pfizer Main Business Overview

13.2.5 Pfizer Latest Developments

13.3 Almirall

13.3.1 Almirall Company Information

13.3.2 Almirall Prescription Dermatological Medications Product Offered

13.3.3 Almirall Prescription Dermatological Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Almirall Main Business Overview

13.3.5 Almirall Latest Developments

13.4 Bausch Health

13.4.1 Bausch Health Company Information

13.4.2 Bausch Health Prescription Dermatological Medications Product Offered

13.4.3 Bausch Health Prescription Dermatological Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Bausch Health Main Business Overview

13.4.5 Bausch Health Latest Developments

13.5 Barrier Therapeutics

13.5.1 Barrier Therapeutics Company Information

13.5.2 Barrier Therapeutics Prescription Dermatological Medications Product Offered

13.5.3 Barrier Therapeutics Prescription Dermatological Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Barrier Therapeutics Main Business Overview

13.5.5 Barrier Therapeutics Latest Developments

13.6 PharmaDerm

13.6.1 PharmaDerm Company Information

13.6.2 PharmaDerm Prescription Dermatological Medications Product Offered

13.6.3 PharmaDerm Prescription Dermatological Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 PharmaDerm Main Business Overview

13.6.5 PharmaDerm Latest Developments

13.7 Bristol-Myers Squibb

13.7.1 Bristol-Myers Squibb Company Information

13.7.2 Bristol-Myers Squibb Prescription Dermatological Medications Product Offered

13.7.3 Bristol-Myers Squibb Prescription Dermatological Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Bristol-Myers Squibb Main Business Overview

13.7.5 Bristol-Myers Squibb Latest Developments

13.8 Galderma

13.8.1 Galderma Company Information

13.8.2 Galderma Prescription Dermatological Medications Product Offered

13.8.3 Galderma Prescription Dermatological Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Galderma Main Business Overview

13.8.5 Galderma Latest Developments

13.9 Novartis

13.9.1 Novartis Company Information

13.9.2 Novartis Prescription Dermatological Medications Product Offered

13.9.3 Novartis Prescription Dermatological Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Novartis Main Business Overview

13.9.5 Novartis Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Prescription Dermatological Medications Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Prescription Dermatological Medications Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Oral

Table 4. Major Players of Topical

Table 5. Global Prescription Dermatological Medications Sales by Type (2017-2022) & (K Units)

Table 6. Global Prescription Dermatological Medications Sales Market Share by Type (2017-2022)

Table 7. Global Prescription Dermatological Medications Revenue by Type (2017-2022) & ($ million)

Table 8. Global Prescription Dermatological Medications Revenue Market Share by Type (2017-2022)

Table 9. Global Prescription Dermatological Medications Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Prescription Dermatological Medications Sales by Application (2017-2022) & (K Units)

Table 11. Global Prescription Dermatological Medications Sales Market Share by Application (2017-2022)

Table 12. Global Prescription Dermatological Medications Revenue by Application (2017-2022)

Table 13. Global Prescription Dermatological Medications Revenue Market Share by Application (2017-2022)

Table 14. Global Prescription Dermatological Medications Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Prescription Dermatological Medications Sales by Company (2020-2022) & (K Units)

Table 16. Global Prescription Dermatological Medications Sales Market Share by Company (2020-2022)

Table 17. Global Prescription Dermatological Medications Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Prescription Dermatological Medications Revenue Market Share by Company (2020-2022)

Table 19. Global Prescription Dermatological Medications Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Prescription Dermatological Medications Producing Area Distribution and Sales Area

Table 21. Players Prescription Dermatological Medications Products Offered

Table 22. Prescription Dermatological Medications Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Prescription Dermatological Medications Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Prescription Dermatological Medications Sales Market Share Geographic Region (2017-2022)

Table 27. Global Prescription Dermatological Medications Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Prescription Dermatological Medications Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Prescription Dermatological Medications Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Prescription Dermatological Medications Sales Market Share by Country/Region (2017-2022)

Table 31. Global Prescription Dermatological Medications Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Prescription Dermatological Medications Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Prescription Dermatological Medications Sales by Country (2017-2022) & (K Units)

Table 34. Americas Prescription Dermatological Medications Sales Market Share by Country (2017-2022)

Table 35. Americas Prescription Dermatological Medications Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Prescription Dermatological Medications Revenue Market Share by Country (2017-2022)

Table 37. Americas Prescription Dermatological Medications Sales by Type (2017-2022) & (K Units)

Table 38. Americas Prescription Dermatological Medications Sales Market Share by Type (2017-2022)

Table 39. Americas Prescription Dermatological Medications Sales by Application (2017-2022) & (K Units)

Table 40. Americas Prescription Dermatological Medications Sales Market Share by Application (2017-2022)

Table 41. APAC Prescription Dermatological Medications Sales by Region (2017-2022) & (K Units)

Table 42. APAC Prescription Dermatological Medications Sales Market Share by Region (2017-2022)

Table 43. APAC Prescription Dermatological Medications Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Prescription Dermatological Medications Revenue Market Share by Region (2017-2022)

Table 45. APAC Prescription Dermatological Medications Sales by Type (2017-2022) & (K Units)

Table 46. APAC Prescription Dermatological Medications Sales Market Share by Type (2017-2022)

Table 47. APAC Prescription Dermatological Medications Sales by Application (2017-2022) & (K Units)

Table 48. APAC Prescription Dermatological Medications Sales Market Share by Application (2017-2022)

Table 49. Europe Prescription Dermatological Medications Sales by Country (2017-2022) & (K Units)

Table 50. Europe Prescription Dermatological Medications Sales Market Share by Country (2017-2022)

Table 51. Europe Prescription Dermatological Medications Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Prescription Dermatological Medications Revenue Market Share by Country (2017-2022)

Table 53. Europe Prescription Dermatological Medications Sales by Type (2017-2022) & (K Units)

Table 54. Europe Prescription Dermatological Medications Sales Market Share by Type (2017-2022)

Table 55. Europe Prescription Dermatological Medications Sales by Application (2017-2022) & (K Units)

Table 56. Europe Prescription Dermatological Medications Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Prescription Dermatological Medications Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Prescription Dermatological Medications Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Prescription Dermatological Medications Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Prescription Dermatological Medications Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Prescription Dermatological Medications Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Prescription Dermatological Medications Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Prescription Dermatological Medications Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Prescription Dermatological Medications Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Prescription Dermatological Medications

Table 66. Key Market Challenges & Risks of Prescription Dermatological Medications

Table 67. Key Industry Trends of Prescription Dermatological Medications

Table 68. Prescription Dermatological Medications Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Prescription Dermatological Medications Distributors List

Table 71. Prescription Dermatological Medications Customer List

Table 72. Global Prescription Dermatological Medications Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Prescription Dermatological Medications Sales Market Forecast by Region

Table 74. Global Prescription Dermatological Medications Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Prescription Dermatological Medications Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Prescription Dermatological Medications Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Prescription Dermatological Medications Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Prescription Dermatological Medications Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Prescription Dermatological Medications Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Prescription Dermatological Medications Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Prescription Dermatological Medications Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Prescription Dermatological Medications Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Prescription Dermatological Medications Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Prescription Dermatological Medications Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Prescription Dermatological Medications Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Prescription Dermatological Medications Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Prescription Dermatological Medications Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Prescription Dermatological Medications Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Prescription Dermatological Medications Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Prescription Dermatological Medications Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Prescription Dermatological Medications Revenue Market Share Forecast by Application (2023-2028)

Table 92. Mylan Pharmaceuticals Basic Information, Prescription Dermatological Medications Manufacturing Base, Sales Area and Its Competitors

Table 93. Mylan Pharmaceuticals Prescription Dermatological Medications Product Offered

Table 94. Mylan Pharmaceuticals Prescription Dermatological Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Mylan Pharmaceuticals Main Business

Table 96. Mylan Pharmaceuticals Latest Developments

Table 97. Pfizer Basic Information, Prescription Dermatological Medications Manufacturing Base, Sales Area and Its Competitors

Table 98. Pfizer Prescription Dermatological Medications Product Offered

Table 99. Pfizer Prescription Dermatological Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Pfizer Main Business

Table 101. Pfizer Latest Developments

Table 102. Almirall Basic Information, Prescription Dermatological Medications Manufacturing Base, Sales Area and Its Competitors

Table 103. Almirall Prescription Dermatological Medications Product Offered

Table 104. Almirall Prescription Dermatological Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Almirall Main Business

Table 106. Almirall Latest Developments

Table 107. Bausch Health Basic Information, Prescription Dermatological Medications Manufacturing Base, Sales Area and Its Competitors

Table 108. Bausch Health Prescription Dermatological Medications Product Offered

Table 109. Bausch Health Prescription Dermatological Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Bausch Health Main Business

Table 111. Bausch Health Latest Developments

Table 112. Barrier Therapeutics Basic Information, Prescription Dermatological Medications Manufacturing Base, Sales Area and Its Competitors

Table 113. Barrier Therapeutics Prescription Dermatological Medications Product Offered

Table 114. Barrier Therapeutics Prescription Dermatological Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Barrier Therapeutics Main Business

Table 116. Barrier Therapeutics Latest Developments

Table 117. PharmaDerm Basic Information, Prescription Dermatological Medications Manufacturing Base, Sales Area and Its Competitors

Table 118. PharmaDerm Prescription Dermatological Medications Product Offered

Table 119. PharmaDerm Prescription Dermatological Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. PharmaDerm Main Business

Table 121. PharmaDerm Latest Developments

Table 122. Bristol-Myers Squibb Basic Information, Prescription Dermatological Medications Manufacturing Base, Sales Area and Its Competitors

Table 123. Bristol-Myers Squibb Prescription Dermatological Medications Product Offered

Table 124. Bristol-Myers Squibb Prescription Dermatological Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. Bristol-Myers Squibb Main Business

Table 126. Bristol-Myers Squibb Latest Developments

Table 127. Galderma Basic Information, Prescription Dermatological Medications Manufacturing Base, Sales Area and Its Competitors

Table 128. Galderma Prescription Dermatological Medications Product Offered

Table 129. Galderma Prescription Dermatological Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. Galderma Main Business

Table 131. Galderma Latest Developments

Table 132. Novartis Basic Information, Prescription Dermatological Medications Manufacturing Base, Sales Area and Its Competitors

Table 133. Novartis Prescription Dermatological Medications Product Offered

Table 134. Novartis Prescription Dermatological Medications Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 135. Novartis Main Business

Table 136. Novartis Latest Developments

List of Figures

Figure 1. Picture of Prescription Dermatological Medications

Figure 2. Prescription Dermatological Medications Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Prescription Dermatological Medications Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Prescription Dermatological Medications Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Prescription Dermatological Medications Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Oral

Figure 10. Product Picture of Topical

Figure 11. Global Prescription Dermatological Medications Sales Market Share by Type in 2021

Figure 12. Global Prescription Dermatological Medications Revenue Market Share by Type (2017-2022)

Figure 13. Prescription Dermatological Medications Consumed in Hospital Pharmacies

Figure 14. Global Prescription Dermatological Medications Market: Hospital Pharmacies (2017-2022) & (K Units)

Figure 15. Prescription Dermatological Medications Consumed in Online Pharmacies

Figure 16. Global Prescription Dermatological Medications Market: Online Pharmacies (2017-2022) & (K Units)

Figure 17. Prescription Dermatological Medications Consumed in Retail Pharmacies

Figure 18. Global Prescription Dermatological Medications Market: Retail Pharmacies (2017-2022) & (K Units)

Figure 19. Global Prescription Dermatological Medications Sales Market Share by Application (2017-2022)

Figure 20. Global Prescription Dermatological Medications Revenue Market Share by Application in 2021

Figure 21. Prescription Dermatological Medications Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Prescription Dermatological Medications Revenue Market Share by Company in 2021

Figure 23. Global Prescription Dermatological Medications Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Prescription Dermatological Medications Revenue Market Share by Geographic Region in 2021

Figure 25. Global Prescription Dermatological Medications Sales Market Share by Region (2017-2022)

Figure 26. Global Prescription Dermatological Medications Revenue Market Share by Country/Region in 2021

Figure 27. Americas Prescription Dermatological Medications Sales 2017-2022 (K Units)

Figure 28. Americas Prescription Dermatological Medications Revenue 2017-2022 ($ Millions)

Figure 29. APAC Prescription Dermatological Medications Sales 2017-2022 (K Units)

Figure 30. APAC Prescription Dermatological Medications Revenue 2017-2022 ($ Millions)

Figure 31. Europe Prescription Dermatological Medications Sales 2017-2022 (K Units)

Figure 32. Europe Prescription Dermatological Medications Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Prescription Dermatological Medications Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Prescription Dermatological Medications Revenue 2017-2022 ($ Millions)

Figure 35. Americas Prescription Dermatological Medications Sales Market Share by Country in 2021

Figure 36. Americas Prescription Dermatological Medications Revenue Market Share by Country in 2021

Figure 37. United States Prescription Dermatological Medications Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Prescription Dermatological Medications Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Prescription Dermatological Medications Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Prescription Dermatological Medications Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Prescription Dermatological Medications Sales Market Share by Region in 2021

Figure 42. APAC Prescription Dermatological Medications Revenue Market Share by Regions in 2021

Figure 43. China Prescription Dermatological Medications Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Prescription Dermatological Medications Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Prescription Dermatological Medications Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Prescription Dermatological Medications Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Prescription Dermatological Medications Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Prescription Dermatological Medications Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Prescription Dermatological Medications Sales Market Share by Country in 2021

Figure 50. Europe Prescription Dermatological Medications Revenue Market Share by Country in 2021

Figure 51. Germany Prescription Dermatological Medications Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Prescription Dermatological Medications Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Prescription Dermatological Medications Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Prescription Dermatological Medications Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Prescription Dermatological Medications Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Prescription Dermatological Medications Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Prescription Dermatological Medications Revenue Market Share by Country in 2021

Figure 58. Egypt Prescription Dermatological Medications Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Prescription Dermatological Medications Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Prescription Dermatological Medications Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Prescription Dermatological Medications Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Prescription Dermatological Medications Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Prescription Dermatological Medications in 2021

Figure 64. Manufacturing Process Analysis of Prescription Dermatological Medications

Figure 65. Industry Chain Structure of Prescription Dermatological Medications

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390